Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt

Author

B. Bloem

View on Semantic Scholar

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Telehealth mindful yoga for balance in Parkinson’s disease: A randomised controlled trial

Abstract Background Impaired balance affects about 80% of people with Parkinson’s disease (PD), leading to falls, injury and reduced quality of life (QoL). Motor and non‑motor deficits (e.g. cognitive decline, anxiety) impair balance control. Mind–body modalities such as mindfulness and yoga may address both domains by...

J.-Y.-Y. Kwok, L. Chan, Y. Shum et al. · 0 citations
Open access Sep 2026

Video-based quantification of leg agility in Parkinson’s disease and its relationship to upper extremity motor impairments

Bradykinesia is a hallmark sign of Parkinson’s disease (PD). Current clinical assessment is susceptible to inter-rater variability and only provides a single, ordinal severity score. Here, we propose a computer vision-based framework to quantify distinct motor characteristics from video recordings of the leg agility...

Tahereh Zarrat Ehsan, M. Tangermann, King-Chung Ho et al. · 0 citations
Review Open access Aug 2026

Neuronal Antibodies in Patients With Atypical Parkinsonism

Routine testing for anti-IgLON5 or other neuronal antibodies in AP is not recommended, but careful clinical phenotyping is essential to uncover additional features that might suggest an underlying antibody-associated disease in selected patient cases.

J. Kerstens, E. Dopper, L. D. Kaat et al. · 0 citations
Editorial Open access Sep 2026

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies

Investigation of anti-α -synuclein immunotherapy as a potential disease-modifying strategy for PD found no evidence of delay in motor progression and exploratory studies suggested potential clinical activity.

A. Boehringer, L. Kalia, B. Bloem et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.